妊娠期疑似肺栓塞先进影像检查的知情同意:拒绝率、结局及降低延迟诊断风险的机会
这项回顾性队列研究纳入2021年10月1日至2023年3月31日21家社区医院中因疑似肺栓塞被推荐先进影像检查的405例妊娠门诊患者,中位年龄30.5岁,50%处于妊娠晚期;83%在非产科场景(99%为急诊科)评估,17%在产科场景。总体314例(78%)同意检查、91例(22%)拒绝;产科场景同意率99% vs 非产科场景73%(p < 0.001),调整人口学和临床变量(包括验前概率)后仅产科场景与同意独立相关(aRR 1.26,95% CI 1.09-1.44)。拒绝者中79例(87%)有30天随访,12例报告症状持续或加重者中8例再次被推荐先进影像并同意,影像均为阴性;初始拒绝者中无人90天内诊断肺栓塞或死亡。作者认为改善知情同意的沟通与记录、对拒绝者确保密切随访可能降低漏诊和延迟诊断肺栓塞的风险。
要点
- 妊娠期疑似肺栓塞被推荐先进影像的405例门诊患者中,91例(22%)拒绝检查,即约五分之一拒绝。
- 产科场景同意率99% vs 非产科场景(99%为急诊科)73%(p < 0.001),非产科场景拒绝更常见。
- 调整人口学和临床变量(包括验前概率)后,仅产科场景与同意独立相关:aRR 1.26(95% CI 1.09-1.44)。
- 拒绝者中79例(87%)有30天随访,12例症状持续或加重者中8例再次被推荐先进影像并同意,影像均为阴性。
- 初始拒绝影像者中无人90天内诊断肺栓塞或死亡。
适用人群与场景
- 妊娠期因疑似肺栓塞接受诊断评估、并被推荐先进(肺血管)影像检查的门诊患者。
- 评估场景为非产科(99%为急诊科)和产科(产房和门诊诊所);405例中83%在非产科场景、17%在产科场景评估。
- 中位年龄30.5岁,50%处于妊娠晚期。
研究设计与关键结果
- 研究类型:回顾性队列研究,21家社区医院,2021年10月1日至2023年3月31日。
- 纳入405例因疑似肺栓塞被推荐先进影像的妊娠门诊患者;主要结局为对先进影像的口头同意。
- 总体314例(78%)同意影像、91例(22%)拒绝影像。
- 产科场景同意率99% vs 非产科场景73%(p < 0.001)。
- 采用准泊松回归调整人口学和临床变量(包括验前概率)后,仅产科场景与同意独立相关:aRR 1.26(95% CI 1.09-1.44)。
- 拒绝影像者中79例(87%)有30天随访;12例报告症状持续或加重者中8例再次被推荐先进影像并同意,影像均为阴性。
- 初始拒绝影像者中无人90天内诊断肺栓塞或死亡。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,改善知情同意的沟通与记录、对拒绝先进影像者确保密切随访,可能降低漏诊和延迟诊断肺栓塞的风险。
- 非产科场景(主要为急诊科)拒绝先进影像的比例高于产科场景(73% vs 99%,p < 0.001),提示该场景的知情同意沟通值得关注。
- 拒绝影像者随访中症状持续或加重时再次推荐先进影像,12例中8例同意且影像均为阴性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Nonconsent to pulmonary vascular (or advanced) imaging for suspected pulmonary embolism (PE) in pregnancy can delay diagnosis and treatment, increasing risk of adverse outcomes. We sought to understand factors associated with consent and understand outcomes after nonconsent.
METHODS: This retrospective cohort study was undertaken across 21 community hospitals from October 1, 2021, through March 31, 2023. We included gravid patients undergoing diagnostics for suspected PE who were recommended advanced imaging. The primary outcome was verbal consent to advanced imaging. Diagnostic settings were nonobstetric (99% emergency departments [EDs]) and obstetrics (labor and delivery and outpatient clinics). Using quasi-Poisson regression, we calculated adjusted relative risks (aRRs) of consenting with 95% confidence intervals (CIs). We also reported symptom resolution and delayed imaging at follow-up and 90-day PE outcomes.
RESULTS: Imaging was recommended for 405 outpatients: median age was 30.5 years; 50% were in the third trimester. Evaluation was more common in nonobstetric (83%) than obstetric settings (17%). Overall, 314 (78%) agreed to imaging and 91 (22%) declined imaging. Consenting was more prevalent in obstetric settings compared with nonobstetric settings: 99% versus 73% (p < 0.001). When adjusted for demographic and clinical variables, including pretest probability, only obstetric setting was independently associated with consenting: aRR 1.26 (95% CI 1.09-1.44). Seventy-nine (87%) patients declining imaging had 30-day follow-up. Eight of 12 who reported persistent or worsening symptoms on follow-up were again recommended advanced imaging and consented. Imaging was negative. None who initially declined imaging were diagnosed with PE or died within 90 days.
CONCLUSIONS: One in five gravid patients suspected of PE declined advanced imaging, more commonly in nonobstetric (principally ED) settings than obstetric settings. Patients symptomatic on follow-up responded favorably to subsequent imaging recommendations without 90-day outcomes. Improving the communication and documentation of informed consent and securing close follow-up for nonconsenters may mitigate risks of missed and delayed PE diagnosis.
参考来源
- Vinson DR, Somers MJ, Qiao E, et al. Consent to advanced imaging in antenatal pulmonary embolism diagnostics: Prevalence, outcomes of nonconsent and opportunities to mitigate delayed diagnosis risk. Acad Emerg Med. 2024. PMID: 39552252. doi:10.1111/acem.15045
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。